| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000020003 |
| Receipt No. | R000018137 |
| Scientific Title | Clinical characteristics and outcome in patients with heart failure: multicenter, prospective, observational study |
| Date of disclosure of the study information | 2015/11/30 |
| Last modified on | 2021/12/04 (Ver. 6) |
| Basic information | ||
| Public title | Clinical characteristics and outcome in patients with heart failure: multicenter, prospective, observational study | |
| Acronym | Clinical characteristics and outcome in patients with heart failure | |
| Scientific Title | Clinical characteristics and outcome in patients with heart failure: multicenter, prospective, observational study | |
| Scientific Title:Acronym | Clinical characteristics and outcome in patients with heart failure | |
| Region |
|
|
| Condition | ||
| Condition | patients with heart failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the clinical characteristics and outcome in patients with heart failure |
| Basic objectives2 | Others |
| Basic objectives -Others | To investigate the clinical characteristics and outcome in patients with heart failure |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Hospitalization and death due to cardiovascular disease |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients who were admitted in hospital due to heart failure | |||
| Key exclusion criteria | Exclusion criteria is age less than 20 years | |||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Graduate school of medical and dental sciences, Kagoshima university | ||||||
| Division name | Cardiovascular medicine and hypertension | ||||||
| Zip code | 890-8520 | ||||||
| Address | 8-35-1, Sakuragaoka, Kagoshima, Japan | ||||||
| TEL | 0992755318 | ||||||
| kubozono@cepp.ne.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Graduate school of medical and dental sciences, Kagoshima university | ||||||
| Division name | Cardiovascular medicine and hypertension | ||||||
| Zip code | 890-8520 | ||||||
| Address | 8-35-1, Sakuragaoka, Kagoshima, Japan | ||||||
| TEL | 0992755318 | ||||||
| Homepage URL | |||||||
| kubozono@cepp.ne.jp | |||||||
| Sponsor | |
| Institute | Graduate school of medical and dental sciences, Kagoshima university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Graduate school of medical and dental sciences, Kagoshima university |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Committee of Kagoshima University |
| Address | 8-35-1, Sakuragaoka, Kagoshima, Japan |
| Tel | 0992756692 |
| kufsyomu@kuas.kagoshima-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | The patients who were hospitalized to treat heart failure are enrolled in this study. The evaluation items in admission and at discharge of this study is as follows:
1. Cause of heart failure 2. Severity of heart failure 3. Treatment of acute phase and at discharge 4. Outcome at discharge We will investigate these evaluation items each year, and hospitalization and death for cardiovascular disease. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018137 |